Business Description
![Getinge AB Getinge AB logo](https://static.gurufocus.com/logos/0C00000XF5.png?14)
Getinge AB
ISIN : SE0000202624
Share Class Description:
MEX:GETIB: Class BCompare
Compare
Traded in other countries / regions
GETI B.Sweden0GZV.UKGNGBY.USAGTN.GermanyGETIB.Mexico IPO Date
2020-12-08Description
Getinge, headquartered in Gothenburg, Sweden, manufactures a wide range of products for use in acute care, surgical, and life sciences in the hospital, pharmaceutical, and research settings. The company reports in three segments: acute care therapies (52% of revenue), surgical workflows (34%), and life sciences (14%). Product areas include ventilators, surgical stents, life support systems, sterilizers, surgical tables, and sterile transfer systems. Getinge derives revenue from a broad geographic footprint, with the Americas accounting for 45% of sales (U.S. 33% of sales), Asia-Pacific 25%, and Europe, Middle East, and Africa the remaining 30%.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.27 | |||||
Equity-to-Asset | 0.57 | |||||
Debt-to-Equity | 0.27 | |||||
Debt-to-EBITDA | 1.37 | |||||
Interest Coverage | 9.68 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 2.84 | |||||
Beneish M-Score | -2.59 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 2.2 | |||||
3-Year EBITDA Growth Rate | -6.4 | |||||
3-Year EPS without NRI Growth Rate | -8.5 | |||||
3-Year FCF Growth Rate | -36.1 | |||||
3-Year Book Growth Rate | 12.8 | |||||
Future 3-5Y EPS without NRI Growth Rate | 12.37 | |||||
Future 3-5Y Total Revenue Growth Rate | 5.15 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.15 | |||||
Quick Ratio | 0.65 | |||||
Cash Ratio | 0.16 | |||||
Days Inventory | 143.54 | |||||
Days Sales Outstanding | 53.87 | |||||
Days Payable | 45.92 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Dividend Growth Rate | 41.5 | |||||
Shareholder Yield % | -1.32 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 46.27 | |||||
Operating Margin % | 13.48 | |||||
Net Margin % | 7.75 | |||||
FCF Margin % | 9.69 | |||||
ROE % | 8.24 | |||||
ROA % | 4.76 | |||||
ROIC % | 6.79 | |||||
ROC (Joel Greenblatt) % | 56.63 | |||||
ROCE % | 9.72 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 22.09 | |||||
Forward PE Ratio | 47.32 | |||||
PE Ratio without NRI | 20.41 | |||||
Shiller PE Ratio | 26.41 | |||||
Price-to-Owner-Earnings | 17.27 | |||||
PEG Ratio | 0.92 | |||||
PS Ratio | 1.71 | |||||
PB Ratio | 1.81 | |||||
Price-to-Free-Cash-Flow | 17.41 | |||||
Price-to-Operating-Cash-Flow | 12.43 | |||||
EV-to-EBIT | 15.2 | |||||
EV-to-EBITDA | 10.04 | |||||
EV-to-Revenue | 1.89 | |||||
EV-to-FCF | 19.34 | |||||
Price-to-Projected-FCF | 1.01 | |||||
Price-to-Median-PS-Value | 1.09 | |||||
Price-to-Peter-Lynch-Fair-Value | 3.13 | |||||
Earnings Yield (Greenblatt) % | 6.58 | |||||
FCF Yield % | 5.77 | |||||
Forward Rate of Return (Yacktman) % | 12.97 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Getinge AB Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil MXN) | 54,985.128 | ||
EPS (TTM) (MXN) | 15.53 | ||
Beta | 0 | ||
Volatility % | 0.77 | ||
14-Day RSI | 0 | ||
14-Day ATR (MXN) | 0 | ||
20-Day SMA (MXN) | 901.62 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (MXN) | 901.62 - 901.62 | ||
Shares Outstanding (Mil) | 272.37 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 7 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Getinge AB Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Getinge AB Stock Events
Event | Date | Price(MXN) | ||
---|---|---|---|---|
No Event Data |
Getinge AB Frequently Asked Questions
What is Getinge AB(MEX:GETIB)'s stock price today?
The current price of MEX:GETIB is MXN901.62. The 52 week high of MEX:GETIB is MXN901.62 and 52 week low is MXN901.62.
When is next earnings date of Getinge AB(MEX:GETIB)?
The next earnings date of Getinge AB(MEX:GETIB) is 2024-10-18.
Does Getinge AB(MEX:GETIB) pay dividends? If so, how much?
Getinge AB(MEX:GETIB) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |